NAMENDA Side Effects

5506960-X | Convulsion, Respiratory Acidosis, Tonic Clonic Movements
on Oct 22, 2007 Female patient from UNITED STATES , 89 years of age, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, respiratory acidosis, tonic clonic movements. Namenda dosage: 5 Mg Qd Po. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), ATIVAN (View Ativan Review and Ativan Label ), ZEGERID (OMEPRAZOLE/SODIUM BICARBONATE) (View Zegerid (omeprazole/sodium Bicarbonate) Review and Zegerid (omeprazole/sodium Bicarbonate) Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

5489206-0 | Accidental Overdose, Asthenia, Condition Aggravated, Confusional State, Dysstasia, Fatigue, Feeling Abnormal, Nausea, Retching
Patient was taking Namenda (View Usage). Patient had the following side effects: accidental overdose, asthenia, condition aggravated, confusional state, dysstasia, fatigue, feeling abnormal, nausea (What is nausea?), retching on Oct 04, 2007 from UNITED STATES Additional patient health information: Male patient , 80 years of age, was diagnosed with dementia alzheimer's type and. Namenda dosage: . During the same period patient was treated with INJECTION (View Injection Review and Injection Label ). Patient was hospitalized.

5484909-6 | Retinal Tear
Adverse event was reported on Oct 01, 2007 by a Male patient taking Namenda (View Usage) (Dosage: 5 Mg Bid Po) was diagnosed with cognitive disorder and. Location: UNITED STATES , 68 years of age, After Namenda was administered, patient had the following side effects: retinal tear. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), ALLEGRA D (FEXOFENADINE AND PSEUDOEPHEDRINE) (View Allegra-d (fexofenadine And Pseudoephedrine) Review and Allegra-d (fexofenadine And Pseudoephedrine) Label ), NASONEX (View Nasonex Review and Nasonex Label ), ARICEPT (View Aricept Review and Aricept Label ).

5481945-0 | Aggression, Nightmare
on Sep 27, 2007 Male patient from UNITED STATES , 73 years of age, was diagnosed with dementia (What is dementia?), insomnia and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, nightmare. Namenda dosage: 5 Mg Bid Po. During the same period patient was treated with LUNESTA (View Lunesta Review and Lunesta Label ), ATIVAN (View Ativan Review and Ativan Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), SINEMET (View Sinemet Review and Sinemet Label ), REQUIP (View Requip Review and Requip Label ), COMTAN (View Comtan Review and Comtan Label ), STALEVO (CARBIDOPA, LEVODOPA AND ENTACAPONE) (View Stalevo (carbidopa, Levodopa And Entacapone) Review and Stalevo (carbidopa, Levodopa And Entacapone) Label ).


5450660-1 | Abasia, Headache, Muscular Weakness, Vomiting
on Sep 04, 2007 Female patient from UNITED STATES , 81 years of age, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). Patient had the following side effects: abasia, headache (What is headache?), muscular weakness, vomiting. Namenda dosage: 5 Mg Qd Po. During the same period patient was treated with PAXIL (View Paxil Review and Paxil Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ), ACCUPRIL (View Accupril Review and Accupril Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), SENNA (View Senna Review and Senna Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ). Patient was hospitalized.

5449560-2 | Retinal Tear
Patient was taking Namenda (View Usage). After Namenda was administered, patient had the following side effects: retinal tear on Aug 28, 2007 from UNITED STATES Additional patient health information: Male patient , 68 years of age, was diagnosed with cognitive disorder and. Namenda dosage: 5 Mg Bid Po. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), ALLEGRA D (FEXOFENADINE AND PSEUDOEPHEDRINE) (View Allegra-d (fexofenadine And Pseudoephedrine) Review and Allegra-d (fexofenadine And Pseudoephedrine) Label ), NASONEX (View Nasonex Review and Nasonex Label ), ARICEPT (View Aricept Review and Aricept Label ).

5444078-5 | Aggression, Nightmare
Adverse event was reported on Aug 23, 2007 by a Male patient taking Namenda (View Usage) (Dosage: 5 Mg Bid Po) was diagnosed with parkinson's disease (What is parkinson's disease?), insomnia and. Location: UNITED STATES , 73 years of age, Patient experienced the following unwanted or unexpected effects: aggression, nightmare. During the same period patient was treated with LUNSETA (ESZOPICLONE) (View Lunseta (eszopiclone) Review and Lunseta (eszopiclone) Label ), ATIVAN (View Ativan Review and Ativan Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), SINEMET (View Sinemet Review and Sinemet Label ), REQUIP (View Requip Review and Requip Label ), COMTAN (View Comtan Review and Comtan Label ), STALEVO (CARBIDOPA, LEVODOPA AND ENTACAPONE) (View Stalevo (carbidopa, Levodopa And Entacapone) Review and Stalevo (carbidopa, Levodopa And Entacapone) Label ).

5420990-8 | Aggression, Ascites, Cardiomegaly, Coagulopathy, Dyspnoea, Hypertension, Mental Status Changes, Nephrolithiasis, Oral Administration Complication
on Aug 09, 2007 Female patient from UNITED STATES , 82 years of age, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). Patient had the following side effects: aggression, ascites, cardiomegaly, coagulopathy, dyspnoea, hypertension, mental status changes, nephrolithiasis, oral administration complication. Namenda dosage: 5 Mg Bid Po. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), DIOVAN (View Diovan Review and Diovan Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), PROCARDIA (View Procardia Review and Procardia Label ), AMARYL (View Amaryl Review and Amaryl Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), SEROQUEL (View Seroquel Review and Seroquel Label ). Patient was hospitalized.

5419211-1 | Blood Iron Decreased, Joint Swelling, Oedema Peripheral, Renal Impairment
on Aug 06, 2007 Female patient from UNITED STATES , 80 years of age, was diagnosed with dementia alzheimer's type, osteoporosis (What is osteoporosis?) and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: blood iron decreased, joint swelling, oedema peripheral, renal impairment. Namenda dosage: 5 Mg Bid Po. During the same period patient was treated with BONIVA (View Boniva Review and Boniva Label ), MUCINEX (View Mucinex Review and Mucinex Label ), LOTREL (View Lotrel Review and Lotrel Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), PAXIL (View Paxil Review and Paxil Label ). Patient was hospitalized.

5412002-7 | Cardiac Arrest
Patient was taking Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?) on Jul 31, 2007 from UNITED STATES Additional patient health information: Female patient , 74 years of age, was diagnosed with dementia alzheimer's type and. Namenda dosage: 10 Mg Bid Po. During the same period patient was treated with RAZADYNE (View Razadyne Review and Razadyne Label ).

5402085-2 | Abasia, Headache, Muscular Weakness, Vomiting
Adverse event was reported on Jul 20, 2007 by a Female patient taking Namenda (View Usage) (Dosage: 5 Mg Po) was diagnosed with dementia (What is dementia?) and. Location: UNITED STATES , 81 years of age, Patient had the following side effects: abasia, headache (What is headache?), muscular weakness, vomiting. During the same period patient was treated with PAXIL (View Paxil Review and Paxil Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ), ACCUPRIL (View Accupril Review and Accupril Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), SENNA (View Senna Review and Senna Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ). Patient was hospitalized.

5402084-0 | Blood Pressure Fluctuation, Blood Pressure Increased
on Jul 20, 2007 Male patient from UNITED STATES , 79 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: blood pressure fluctuation, blood pressure increased. Namenda dosage: 5 Mg Qd Po. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5398606-9 | Cerebrovascular Accident, Chest Discomfort, Dizziness, Dyspnoea, Gait Disturbance, Headache, Hypoaesthesia, Vomiting
on Jul 09, 2007 Male patient from UNITED STATES , 84 years of age, was diagnosed with amnesia and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, chest discomfort, dizziness (What is dizziness?), dyspnoea, gait disturbance, headache (What is headache?), hypoaesthesia, vomiting. Namenda dosage: 5 Mcg Qd; Po. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), MULTIVITAMIN (NOS) (View Multivitamin (nos) Review and Multivitamin (nos) Label ), GINKO BILOBA (View Ginko Biloba Review and Ginko Biloba Label ). Patient was hospitalized.

5397116-2 | Abasia, Activities Of Daily Living Impaired, Blood Potassium Decreased, Condition Aggravated, Contusion, Dementia Alzheimer's Type, Fall, Feeding Disorder, Starvation
Patient was taking Namenda (View Usage). Patient had the following side effects: abasia, activities of daily living impaired, blood potassium decreased, condition aggravated, contusion, dementia alzheimer's type, fall (What is fall?), feeding disorder, starvation on Jul 16, 2007 from UNITED STATES Additional patient health information: Male patient , 84 years of age, was diagnosed with dementia alzheimer's type and. Namenda dosage: . During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PROSCAR (View Proscar Review and Proscar Label ), ACE INHIBITOR (View Ace Inhibitor Review and Ace Inhibitor Label ), VITAMINS NOS (View Vitamins Nos Review and Vitamins Nos Label ), EYE DROPS (NOS) (View Eye Drops (nos) Review and Eye Drops (nos) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5391044-4 | International Normalised Ratio Increased
Adverse event was reported on Jul 10, 2007 by a Male patient taking Namenda (View Usage) (Dosage: ) was diagnosed with dementia alzheimer's type, atrial fibrillation (What is atrial fibrillation?) and. Location: UNITED STATES , 77 years of age, After Namenda was administered, patient had the following side effects: international normalised ratio increased. During the same period patient was treated with COUMADIN (5 Mg Qw Po) (View Coumadin Review and Coumadin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ARICEPT (View Aricept Review and Aricept Label ).

5391043-2 | International Normalised Ratio
on Jul 10, 2007 Male patient from UNITED KINGDOM , 66 years of age, was diagnosed with memory impairment, heart valve replacement, postoperative care and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio. Namenda dosage: . During the same period patient was treated with COUMADIN (7.5 Mg Qd Po) (View Coumadin Review and Coumadin Label ), XALATAN (View Xalatan Review and Xalatan Label ), COMBIVERT (ALBUTEROL/IPRATROPIUM) (View Combivert (albuterol/ipratropium) Review and Combivert (albuterol/ipratropium) Label ), NITROQUICK (GLYCERYL TRINITRATE) (View Nitroquick (glyceryl Trinitrate) Review and Nitroquick (glyceryl Trinitrate) Label ), TRILEPTAL (View Trileptal Review and Trileptal Label ).

5387181-0 | Blood Iron Decreased, Joint Swelling, Oedema Peripheral, Renal Impairment
on Jul 03, 2007 Female patient from UNITED STATES , 80 years of age, was diagnosed with dementia alzheimer's type, osteoporosis (What is osteoporosis?) and was treated with Namenda (View Usage). Patient had the following side effects: blood iron decreased, joint swelling, oedema peripheral, renal impairment. Namenda dosage: 5 Mg Bid Po. During the same period patient was treated with BONIVA (View Boniva Review and Boniva Label ), MUCINEX (View Mucinex Review and Mucinex Label ), LOTREL (View Lotrel Review and Lotrel Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), PAXIL (View Paxil Review and Paxil Label ). Patient was hospitalized.

5387180-9 | Anxiety, Condition Aggravated, Confusional State, Gait Disturbance, Hypoglycaemia, Tremor, Upper Respiratory Tract Infection
Patient was taking Namenda (View Usage). After Namenda was administered, patient had the following side effects: anxiety (What is anxiety?), condition aggravated, confusional state, gait disturbance, hypoglycaemia, tremor, upper respiratory tract infection on Jul 02, 2007 from UNITED STATES Additional patient health information: Female patient , 82 years of age, was diagnosed with dementia alzheimer's type, cough and. Namenda dosage: 10 Mg Qd Po. During the same period patient was treated with DEXTROMETHORPHAN (2 Q4hr) (View Dextromethorphan Review and Dextromethorphan Label ), BETOPTIC (View Betoptic Review and Betoptic Label ).

5379377-9 | Catatonia, Confusional State, Convulsion, Depressed Level Of Consciousness, Disorientation, Encephalitis, Feeling Abnormal, Hypertensive Crisis
Adverse event was reported on Jun 26, 2007 by a Female patient taking Namenda (View Usage) (Dosage: ) . Location: UNITED STATES , 76 years of age, Patient experienced the following unwanted or unexpected effects: catatonia, confusional state, convulsion, depressed level of consciousness, disorientation, encephalitis (What is encephalitis?), feeling abnormal, hypertensive crisis. During the same period patient was treated with LUNESTA (View Lunesta Review and Lunesta Label ), ARICEPT (View Aricept Review and Aricept Label ), ULTRAM (View Ultram Review and Ultram Label ), LORTAB (HYDROCODONE) (View Lortab (hydrocodone) Review and Lortab (hydrocodone) Label ), NAPROSYN (View Naprosyn Review and Naprosyn Label ), KLONOPIN (View Klonopin Review and Klonopin Label ). Patient was hospitalized.

5378261-4 | Asthenia, Muscle Rigidity, Somnolence, Treatment Noncompliance
on Jun 19, 2007 Female patient from UNITED STATES , 83 years of age, was diagnosed with dementia (What is dementia?), dementia alzheimer's type and was treated with Namenda (View Usage). Patient had the following side effects: asthenia, muscle rigidity, somnolence, treatment noncompliance. Namenda dosage: . During the same period patient was treated with CYMBALTA (DULOXETINE HCI) (View Cymbalta (duloxetine Hci) Review and Cymbalta (duloxetine Hci) Label ), ACTONEL (View Actonel Review and Actonel Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), GLYCOLAX (View Glycolax Review and Glycolax Label ). Patient was hospitalized.

5373972-9 | Abnormal Behaviour, Confusional State, Disease Progression, Dyspnoea, Mood Swings, Neuropathy Peripheral
on Jun 18, 2007 Female patient from UNITED STATES , 42 years of age, was diagnosed with neuropathy peripheral, complex regional pain syndrome (What is complex regional pain syndrome?) and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: abnormal behaviour, confusional state, disease progression, dyspnoea, mood swings, neuropathy peripheral. Namenda dosage: 10 Mg Bid Po. During the same period patient was treated with MS CONTIN (15 Mg Qd Po) (View Ms Contin Review and Ms Contin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), CRESTOR (View Crestor Review and Crestor Label ), DARVOCET (View Darvocet Review and Darvocet Label ).

5369584-3 | Blood Potassium Decreased, Condition Aggravated, Contusion, Dementia, Fall, Wrist Fracture
Patient was taking Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium decreased, condition aggravated, contusion, dementia (What is dementia?), fall (What is fall?), wrist fracture on Jun 14, 2007 from UNITED STATES Additional patient health information: Male patient , 84 years of age, was diagnosed with dementia alzheimer's type and. Namenda dosage: . During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PROSCAR (View Proscar Review and Proscar Label ), ACE INHIBITOR (NOS) (View Ace Inhibitor (nos) Review and Ace Inhibitor (nos) Label ), VITAMINS NOS (View Vitamins Nos Review and Vitamins Nos Label ), EYE DROPS (View Eye Drops Review and Eye Drops Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5369488-6 | Blood Potassium Decreased, Condition Aggravated, Contusion, Dementia, Fall, Wrist Fracture
Adverse event was reported on Jun 14, 2007 by a Male patient taking Namenda (View Usage) (Dosage: ) was diagnosed with dementia alzheimer's type and. Location: UNITED STATES , 84 years of age, Patient had the following side effects: blood potassium decreased, condition aggravated, contusion, dementia (What is dementia?), fall (What is fall?), wrist fracture. During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PROSCAR (View Proscar Review and Proscar Label ), ACE INHIBITOR (NOS) (View Ace Inhibitor (nos) Review and Ace Inhibitor (nos) Label ), EYE DROPS (NOS) (View Eye Drops (nos) Review and Eye Drops (nos) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5339789-6 | Cardiac Arrest
on May 14, 2007 Female patient from UNITED STATES , 74 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?). Namenda dosage: 10 Mg Bid Po. During the same period patient was treated with RAZADYNE (View Razadyne Review and Razadyne Label ).

5335488-5 | Cough, Gait Disturbance, Hypoglycaemia
on May 08, 2007 Female patient from UNITED STATES , 82 years of age, was diagnosed with dementia alzheimer's type, cough and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: cough, gait disturbance, hypoglycaemia. Namenda dosage: 10 Mg Qd Po. During the same period patient was treated with DEXTROMETHORPHAN (2 Q4hr) (View Dextromethorphan Review and Dextromethorphan Label ), BETOPTIC (View Betoptic Review and Betoptic Label ).

5333889-2 | Blood Glucose Fluctuation, Blood Glucose Increased, Refusal Of Treatment By Patient
Patient was taking Namenda (View Usage). Patient had the following side effects: blood glucose fluctuation, blood glucose increased, refusal of treatment by patient on May 15, 2007 from UNITED STATES Additional patient health information: Female patient , 75 years of age, was diagnosed with amnesia and. Namenda dosage: 5 Mg Bid Po. During the same period patient was treated with GLUCOTROL (View Glucotrol Review and Glucotrol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), COREG (View Coreg Review and Coreg Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ).

5328109-9 | Atrial Fibrillation, International Normalised Ratio Increased
Adverse event was reported on May 07, 2007 by a Male patient taking Namenda (View Usage) (Dosage: ) was diagnosed with dementia alzheimer's type, atrial fibrillation (What is atrial fibrillation?) and. Location: UNITED STATES , 77 years of age, After Namenda was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), international normalised ratio increased. During the same period patient was treated with COUMADIN (5 Mg Qw Po) (View Coumadin Review and Coumadin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ARICEPT (View Aricept Review and Aricept Label ).

5328108-7 | International Normalised Ratio Increased
on May 07, 2007 Male patient from UNITED STATES , 66 years of age, was diagnosed with memory impairment, heart valve replacement and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased. Namenda dosage: . During the same period patient was treated with COUMADIN (7.5 Mg Qd Po) (View Coumadin Review and Coumadin Label ), XALATAN (View Xalatan Review and Xalatan Label ), COMBIVENT (ALBUTEROL/IPRATROPIUM) (View Combivent (albuterol/ipratropium) Review and Combivent (albuterol/ipratropium) Label ), NITROQUICK (GLYCERYL TRINITRATE) (View Nitroquick (glyceryl Trinitrate) Review and Nitroquick (glyceryl Trinitrate) Label ), TRILEPTAL (View Trileptal Review and Trileptal Label ), FLOMAX (View Flomax Review and Flomax Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ).

5328106-3 | International Normalised Ratio Increased
on May 07, 2007 Female patient from UNITED STATES , 67 years of age, was diagnosed with memory impairment, atrial fibrillation (What is atrial fibrillation?) and was treated with Namenda (View Usage). Patient had the following side effects: international normalised ratio increased. Namenda dosage: . During the same period patient was treated with COUMADIN (5 Mg Po) (View Coumadin Review and Coumadin Label ), NABUMETONE (View Nabumetone Review and Nabumetone Label ), ALLEGRA (View Allegra Review and Allegra Label ), ARICEPT (View Aricept Review and Aricept Label ), EFFEXOR (View Effexor Review and Effexor Label ).

5326299-5 | Abnormal Behaviour, Aggression, Delirium, Hallucination
Patient was taking Namenda (View Usage). After Namenda was administered, patient had the following side effects: abnormal behaviour, aggression, delirium, hallucination on May 14, 2007 from UNITED STATES Additional patient health information: Male patient , 95 years of age, was diagnosed with dementia alzheimer's type and. Namenda dosage: 10mg Daily In Morning Po; 5mg Daily In Evening Po.

5324929-5 | Contusion, Fatigue, Platelet Count Decreased
Adverse event was reported on Apr 27, 2007 by a Male patient taking Namenda (View Usage) (Dosage: 10 Mg Bid Po) was diagnosed with dementia alzheimer's type, depression (What is depression?) and. Location: UNITED STATES , 78 years of age, Patient experienced the following unwanted or unexpected effects: contusion, fatigue, platelet count decreased. During the same period patient was treated with ZOLOFT (200 Mg Qhs) (View Zoloft Review and Zoloft Label ), COUMADIN (View Coumadin Review and Coumadin Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), RAZADYNE (GALANTINE) (View Razadyne (galantine) Review and Razadyne (galantine) Label ). Patient was hospitalized.

5324928-3 | Abnormal Behaviour, Amnesia, Back Pain, Cognitive Disorder, Complex Regional Pain Syndrome, Condition Aggravated, Confusional State, Dyspnoea
on Apr 27, 2007 Female patient from UNITED STATES , 42 years of age, was diagnosed with neuropathy peripheral, complex regional pain syndrome (What is complex regional pain syndrome?) and was treated with Namenda (View Usage). Patient had the following side effects: abnormal behaviour, amnesia, back pain (What is back pain?), cognitive disorder, complex regional pain syndrome (What is complex regional pain syndrome?), condition aggravated, confusional state, dyspnoea. Namenda dosage: 10 Mg Bid Po. During the same period patient was treated with MS CONTIN (15 Mg Qd Po) (View Ms Contin Review and Ms Contin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), CRESTOR (View Crestor Review and Crestor Label ), DARVOCET (View Darvocet Review and Darvocet Label ).

5307699-6 | Ascites, Cardiomegaly, Condition Aggravated, Dyspnoea, Hypertension, Mental Status Changes, Nephrolithiasis, Tachycardia
on Apr 11, 2007 Female patient from UNITED STATES , 82 years of age, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: ascites, cardiomegaly, condition aggravated, dyspnoea, hypertension, mental status changes, nephrolithiasis, tachycardia. Namenda dosage: 5 Mg Bid Po. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), DIOVAN (View Diovan Review and Diovan Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), PROCARDIA (View Procardia Review and Procardia Label ), AMARYL (View Amaryl Review and Amaryl Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), DESYRL (TRAZODONE) (View Desyrl (trazodone) Review and Desyrl (trazodone) Label ). Patient was hospitalized.

5305554-9 | International Normalised Ratio Increased
Patient was taking Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased on Apr 10, 2007 from UNITED STATES Additional patient health information: Female patient , 67 years of age, was diagnosed with memory impairment, atrial fibrillation (What is atrial fibrillation?) and. Namenda dosage: . During the same period patient was treated with COUMADIN (5 Mg Unk Po) (View Coumadin Review and Coumadin Label ), NABUMETONE (View Nabumetone Review and Nabumetone Label ), ALLEGRA (View Allegra Review and Allegra Label ), ARICEPT (View Aricept Review and Aricept Label ), EFFEXOR (View Effexor Review and Effexor Label ).

5305544-6 | International Normalised Ratio Increased
Adverse event was reported on Apr 10, 2007 by a Male patient taking Namenda (View Usage) (Dosage: ) was diagnosed with dementia alzheimer's type, atrial fibrillation (What is atrial fibrillation?) and. Location: UNITED STATES , 77 years of age, Patient had the following side effects: international normalised ratio increased. During the same period patient was treated with COUMADIN (5 Mg Qw Po) (View Coumadin Review and Coumadin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ARICEPT (View Aricept Review and Aricept Label ).

5305113-8 | International Normalised Ratio Increased
on Apr 10, 2007 Male patient from UNITED STATES , 66 years of age, was diagnosed with memory impairment, mechanical complication of implant and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: international normalised ratio increased. Namenda dosage: . During the same period patient was treated with COUMADIN (7.5 Mg Qd Po) (View Coumadin Review and Coumadin Label ), XALATAN (View Xalatan Review and Xalatan Label ), COMBIVENT (ALBUTEROL/IPRATROPIUM) (View Combivent (albuterol/ipratropium) Review and Combivent (albuterol/ipratropium) Label ), NITROQUICK (GLYCERYL TRINITRATE) (View Nitroquick (glyceryl Trinitrate) Review and Nitroquick (glyceryl Trinitrate) Label ), TRILEPTAL (View Trileptal Review and Trileptal Label ), FLOMAX (View Flomax Review and Flomax Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ).

5298473-8 | Blood Glucose Fluctuation, Blood Glucose Increased, Refusal Of Treatment By Patient
on Apr 03, 2007 Female patient from UNITED STATES , 75 years of age, was diagnosed with amnesia and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose fluctuation, blood glucose increased, refusal of treatment by patient. Namenda dosage: 5 Mg Bid Po. During the same period patient was treated with GLUCOTROL (View Glucotrol Review and Glucotrol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), COREG (View Coreg Review and Coreg Label ), VITAMINS NOS (View Vitamins Nos Review and Vitamins Nos Label ).

5272407-4 | Acute Myocardial Infarction, Aortic Aneurysm, Blood Pressure Inadequately Controlled, Diverticulum, Fall, Haemoglobin Decreased, Hiatus Hernia, Nightmare, Upper Gastrointestinal Haemorrhage
Patient was taking Namenda (View Usage). Patient had the following side effects: acute myocardial infarction, aortic aneurysm (What is aortic aneurysm?), blood pressure inadequately controlled, diverticulum, fall (What is fall?), haemoglobin decreased, hiatus hernia, nightmare, upper gastrointestinal haemorrhage on Mar 13, 2007 from UNITED STATES Additional patient health information: Female patient , 82 years of age, weighting 117.9 lb, was diagnosed with dementia alzheimer's type and. Namenda dosage: 10 Mg Bid Po. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

5268315-5 | Blood Glucose Increased, Refusal Of Treatment By Patient
Adverse event was reported on Mar 08, 2007 by a Female patient taking Namenda (View Usage) (Dosage: 5 Mg Bid Po) was diagnosed with amnesia and. Location: UNITED STATES , 75 years of age, After Namenda was administered, patient had the following side effects: blood glucose increased, refusal of treatment by patient. During the same period patient was treated with GLUCOTROL (View Glucotrol Review and Glucotrol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), COREG (View Coreg Review and Coreg Label ), VITAMINS NOS (View Vitamins Nos Review and Vitamins Nos Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ).

5267416-5 | Abnormal Behaviour, Amnesia, Back Pain, Confusional State, Disease Progression, Dyspnoea, Hyperaesthesia, Mood Swings
on Mar 02, 2007 Female patient from UNITED STATES , 42 years of age, was diagnosed with neuropathy peripheral, complex regional pain syndrome (What is complex regional pain syndrome?) and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, amnesia, back pain (What is back pain?), confusional state, disease progression, dyspnoea, hyperaesthesia, mood swings. Namenda dosage: 10 Mg Bid Po. During the same period patient was treated with MS CONTIN (15 Mg Qd Po) (View Ms Contin Review and Ms Contin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), CRESTOR (View Crestor Review and Crestor Label ), DARVOCET (PROPOXYPHENE/ACETAMINOPHEN) (View Darvocet (propoxyphene/acetaminophen) Review and Darvocet (propoxyphene/acetaminophen) Label ).

5267409-8 | Polymyalgia Rheumatica
on Mar 06, 2007 Male patient from UNITED STATES , 72 years of age, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). Patient had the following side effects: polymyalgia rheumatica (What is polymyalgia rheumatica?). Namenda dosage: 10 Mg Bid Po. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ).

5267408-6 | Convulsion, Dementia Alzheimer's Type, Disease Progression, Urinary Tract Infection
Patient was taking Namenda (View Usage). After Namenda was administered, patient had the following side effects: convulsion, dementia alzheimer's type, disease progression, urinary tract infection (What is urinary tract infection?) on Mar 09, 2007 from UNITED STATES Additional patient health information: Female patient , 63 years of age, was diagnosed with dementia alzheimer's type, convulsion and. Namenda dosage: 10 Mg Bid Po. During the same period patient was treated with ARICEPT (10 Mg Qd) (View Aricept Review and Aricept Label ), DILANTIN (View Dilantin Review and Dilantin Label ), KEPPRA (View Keppra Review and Keppra Label ). Patient was hospitalized.

5259713-4 | Hypertension, Tremor, Urinary Tract Infection
Adverse event was reported on Feb 21, 2007 by a Female patient taking Namenda (View Usage) (Dosage: 5 Mg;daily;oral; 5 Mg; Twice A Day; Oral) was diagnosed with aphasia (What is aphasia?), hypertension and. Location: UNITED STATES , 66 years of age, Patient experienced the following unwanted or unexpected effects: hypertension, tremor, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with METOPROLOL TARTRATE (15 Mg; Daily;oral) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), LEXAPRO (CON.) (View Lexapro (con.) Review and Lexapro (con.) Label ), ARICEPT (CON.) (View Aricept (con.) Review and Aricept (con.) Label ). Patient was hospitalized.

5248396-5 | Agoraphobia, Condition Aggravated, Confusional State, Constipation, Depression, Dysgeusia, Electrocardiogram Abnormal, Micturition Urgency
on Feb 16, 2007 Female patient from UNITED STATES , 76 years of age, weighting 150.0 lb, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). Patient had the following side effects: agoraphobia, condition aggravated, confusional state, constipation (What is constipation?), depression (What is depression?), dysgeusia, electrocardiogram abnormal, micturition urgency. Namenda dosage: 5 Mg Qd Po. During the same period patient was treated with ARICEPT (5 Mg Qd Po) (View Aricept Review and Aricept Label ), DIOVAN (View Diovan Review and Diovan Label ), INSULIN (View Insulin Review and Insulin Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ).

5246746-7 | Hypotension, Syncope
on Feb 09, 2007 Male patient from UNITED STATES , 87 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: hypotension, syncope. Namenda dosage: 10 Mg Bid Po. During the same period patient was treated with RAZADYNE ER (16.5 Mg Qd) (View Razadyne Er Review and Razadyne Er Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

5245599-0 | Agitation, Convulsion, Cyanosis, Dementia Alzheimer's Type, Disease Progression, Nausea, Somnolence, Urinary Tract Infection
Patient was taking Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, convulsion, cyanosis, dementia alzheimer's type, disease progression, nausea (What is nausea?), somnolence, urinary tract infection (What is urinary tract infection?) on Feb 07, 2007 from UNITED STATES Additional patient health information: Female patient , 63 years of age, was diagnosed with dementia alzheimer's type, convulsion and. Namenda dosage: 10 Mg Bid Po. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), DILANTIN (View Dilantin Review and Dilantin Label ), KEPPRA (View Keppra Review and Keppra Label ). Patient was hospitalized.

5242221-4 | Anorexia, Asthenia, Starvation, Weight Decreased
Adverse event was reported on Feb 15, 2007 by a Male patient taking Namenda (View Usage) (Dosage: ) . Location: UNITED STATES , 88 years of age, weighting 80.00 lb, Patient had the following side effects: anorexia, asthenia, starvation, weight decreased. During the same period patient was treated with REMERON (View Remeron Review and Remeron Label ).

5235023-6 | Polymyalgia Rheumatica
on Jan 30, 2007 Male patient from UNITED STATES , 72 years of age, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: polymyalgia rheumatica (What is polymyalgia rheumatica?). Namenda dosage: 10 Mg Bid Po. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ).

5225887-4 | Agitation, Hallucination
on Jan 30, 2007 Female patient from UNITED STATES , 78 years of age, weighting 112.4 lb, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, hallucination. Namenda dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), QUININE (View Quinine Review and Quinine Label ), VYTORIN (View Vytorin Review and Vytorin Label ), DONEPEZIL HCL (View Donepezil Hcl Review and Donepezil Hcl Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

5221750-3 | Aggression, Agitation, Disease Progression, Failure To Thrive, Oral Intake Reduced
Patient was taking Namenda (View Usage). Patient had the following side effects: aggression, agitation, disease progression, failure to thrive, oral intake reduced on Jan 16, 2007 from UNITED STATES Additional patient health information: Female patient , 82 years of age, weighting 90.39 lb, was diagnosed with dementia alzheimer's type and. Namenda dosage: 20 Mg Qd Po. During the same period patient was treated with ARICEPT (20 Mg Qd Po) (View Aricept Review and Aricept Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), EFFEXOR (View Effexor Review and Effexor Label ), REMERON (View Remeron Review and Remeron Label ). Patient was hospitalized.